Document ID: chunk:federal_register_of_legislation:F2025L00215:schedule:1:p5
Version: federal_register_of_legislation:F2025L00215
Segment Type: schedule
Provision Reference: sch 1 (pt 5/51)
Character Range: 13540–16484

MP NP     C4910   P4910   20  3     10

[22] Schedule 1, Part 1, after entry for Enoxaparin in the form Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe [Brand: Exarane Forte; Maximum Quantity: 10; Number of Repeats: 3]
insert:
Enoxaparin  Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe  Injection  Exarane Forte Safety-Lock  JO  MP MW NP  C16261  P16261  10  1     10
Enoxaparin  Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe  Injection  Exarane Forte Safety-Lock  JO  MP NP     C4910   P4910   10  3     10

[23] Schedule 1, Part 1, after entry for Enoxaparin in the form Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe [Brand: Exarane Forte; Maximum Quantity: 10; Number of Repeats: 3]
insert:
Enoxaparin  Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe  Injection  Exarane Forte Safety-Lock  JO  MP MW NP  C16261  P16261  10  1     10
Enoxaparin  Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe  Injection  Exarane Forte Safety-Lock  JO  MP NP     C4910   P4910   10  3     10

[24] Schedule 1, Part 1, entries for Entecavir in the form Tablet 1 mg (as monohydrate)
omit:
Entecavir  Tablet 1 mg (as monohydrate)  Oral  Entecavir Mylan  AF  MP NP  C5037 C5044     60  5     30     D(100)

[25] Schedule 1, Part 1, after entry for Erlotinib in the form Tablet 100 mg (as hydrochloride) [Brand: Erlotinib APOTEX]
insert:
Erlotinib  Tablet 100 mg (as hydrochloride)  Oral  ERLOTINIB ARX  XT  MP  C4473 C4600 C7446     30  3     30

[26] Schedule 1, Part 1, after entry for Estradiol in the form Tablet containing estradiol valerate 2 mg [Maximum Quantity: 112; Number of Repeats: 2]
insert:
Estradiol  Transdermal gel (pump pack) 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses  Transdermal  Estrogel  HB  MP NP             1  5     1
Estradiol  Transdermal gel (pump pack) 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses  Transdermal  Estrogel  HB  MP NP     P14238  2  5     1

[27] Schedule 1, Part 1, entries for Estradiol in the form Transdermal patches 1.17 mg, 8
omit:
Estradiol  Transdermal patches 1.17 mg, 8  Transdermal  Estradiol Transdermal System (Sandoz, USA)  HX  MP NP        1  5     1

[28] Schedule 1, Part 1, after entry for Estradiol in the form Transdermal patches 1.56 mg, 8 [Brand: Estradot 100]
insert:
Estradiol  Transdermal patches 1.56 mg, 24 (Sandoz) (S19A)  Transdermal  Estramon (Germany, Sandoz)  SZ  MP NP        1  1     1

[29] Schedule 1, Part 1, after entry for Estradiol with norethisterone in the form Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 [Maximum Quantity: 2; Number of Repeats: 5]
insert:
Estradiol with norethisterone